In one study, microarray analysis was conducted on PARP-1 gene expression in over 8000 tumor samples [181], revealing higher expression levels of PARP-1 in breast, ovarian, endometrial, lung and skin cancers compared to equivalent amounts of normal tissues. This evidence concerns the gene PARP1 and skin neoplasm.